Harnessing natural killer cells to target HIV-1 persistence

Standard

Harnessing natural killer cells to target HIV-1 persistence. / Joshi, Vinita R; Altfeld, Marcus.

in: CURR OPIN HIV AIDS, Jahrgang 19, Nr. 3, 01.05.2024, S. 141-149.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{9ae33931da8a4e8ca73383cab023ca9d,
title = "Harnessing natural killer cells to target HIV-1 persistence",
abstract = "PURPOSE OF REVIEW: The purpose of this article is to review recent advances in the role of natural killer (NK) cells in approaches aimed at reducing the latent HIV-1 reservoir.RECENT FINDINGS: Multiple approaches to eliminate cells harboring latent HIV-1 are being explored, but have been met with limited success so far. Recent studies have highlighted the role of NK cells and their potential in HIV-1 cure efforts. Anti-HIV-1 NK cell function can be optimized by enhancing NK cell activation, antibody dependent cellular cytotoxicity, reversing inhibition of NK cells as well as by employing immunotherapeutic complexes to enable HIV-1 specificity of NK cells. While NK cells alone do not eliminate the HIV-1 reservoir, boosting NK cell function might complement other strategies involving T cell and B cell immunity towards an HIV-1 functional cure.SUMMARY: Numerous studies focusing on targeting latently HIV-1-infected cells have emphasized a potential role of NK cells in these strategies. Our review highlights recent advances in harnessing NK cells in conjunction with latency reversal agents and other immunomodulatory therapeutics to target HIV-1 persistence.",
author = "Joshi, {Vinita R} and Marcus Altfeld",
note = "Copyright {\textcopyright} 2024 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2024",
month = may,
day = "1",
doi = "10.1097/COH.0000000000000848",
language = "English",
volume = "19",
pages = "141--149",
journal = "CURR OPIN HIV AIDS",
issn = "1746-630X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Harnessing natural killer cells to target HIV-1 persistence

AU - Joshi, Vinita R

AU - Altfeld, Marcus

N1 - Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

PY - 2024/5/1

Y1 - 2024/5/1

N2 - PURPOSE OF REVIEW: The purpose of this article is to review recent advances in the role of natural killer (NK) cells in approaches aimed at reducing the latent HIV-1 reservoir.RECENT FINDINGS: Multiple approaches to eliminate cells harboring latent HIV-1 are being explored, but have been met with limited success so far. Recent studies have highlighted the role of NK cells and their potential in HIV-1 cure efforts. Anti-HIV-1 NK cell function can be optimized by enhancing NK cell activation, antibody dependent cellular cytotoxicity, reversing inhibition of NK cells as well as by employing immunotherapeutic complexes to enable HIV-1 specificity of NK cells. While NK cells alone do not eliminate the HIV-1 reservoir, boosting NK cell function might complement other strategies involving T cell and B cell immunity towards an HIV-1 functional cure.SUMMARY: Numerous studies focusing on targeting latently HIV-1-infected cells have emphasized a potential role of NK cells in these strategies. Our review highlights recent advances in harnessing NK cells in conjunction with latency reversal agents and other immunomodulatory therapeutics to target HIV-1 persistence.

AB - PURPOSE OF REVIEW: The purpose of this article is to review recent advances in the role of natural killer (NK) cells in approaches aimed at reducing the latent HIV-1 reservoir.RECENT FINDINGS: Multiple approaches to eliminate cells harboring latent HIV-1 are being explored, but have been met with limited success so far. Recent studies have highlighted the role of NK cells and their potential in HIV-1 cure efforts. Anti-HIV-1 NK cell function can be optimized by enhancing NK cell activation, antibody dependent cellular cytotoxicity, reversing inhibition of NK cells as well as by employing immunotherapeutic complexes to enable HIV-1 specificity of NK cells. While NK cells alone do not eliminate the HIV-1 reservoir, boosting NK cell function might complement other strategies involving T cell and B cell immunity towards an HIV-1 functional cure.SUMMARY: Numerous studies focusing on targeting latently HIV-1-infected cells have emphasized a potential role of NK cells in these strategies. Our review highlights recent advances in harnessing NK cells in conjunction with latency reversal agents and other immunomodulatory therapeutics to target HIV-1 persistence.

U2 - 10.1097/COH.0000000000000848

DO - 10.1097/COH.0000000000000848

M3 - SCORING: Journal article

C2 - 38457230

VL - 19

SP - 141

EP - 149

JO - CURR OPIN HIV AIDS

JF - CURR OPIN HIV AIDS

SN - 1746-630X

IS - 3

ER -